Ledger.Open graph →
SEC Form D · filed September 17, 2024

Rivus Pharmaceuticals, Inc

Offering
$66.0M
Sold
$66.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHARLOTTESVILLE, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Derek Dirocco · Charlottesville, VADirectorNancy Hargreaves · Charlottesville, VAExecJayson Dallas · Charlottesville, VAExec · DirectorIan Smith · Charlottesville, VADirectorShaharyar Khan · Charlottesville, VAExec · DirectorRick Winningham · Charlottesville, VADirectorFrancesco De Rubertis · Charlottesville, VADirectorAllen Cunningham · Charlottesville, VAExec · DirectorShaharyar Khan · Charlottesville, VAExec · DirectorIan Smith · Charlottesville, VADirectorJayson Dallas · Charlottesville, VAExec · DirectorRick Winningham · Charlottesville, VADirectorAllen Cunningham · Charlottesville, VAExec · DirectorFrancesco De Rubertis · Charlottesville, VADirectorNancy Hargreaves · Charlottesville, VAExecDerek Dirocco · Charlottesville, VADirectorFrancesco Orselli · Rye Brook, NYDirectorPeter A. Blackburn · Senningerberg, LuxembourgExec · DirectorRobert J. Allin · London, United KingdomDirectorNeil Mackie · Singapore, U0DirectorStacey-Ann Kirkconnell · Singapore, U0ExecJonathan Hua Jun Xiong · Singapore, U0DirectorPassco Companies, LLC · Irvine, CAExec · DirectorAkshay Vachhani · Seattle, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗